Written by the Nuvirox Research Team
Key points
- A 2023 Science paper reported that circulating taurine falls with age across species and that restoring it extended lifespan in mice and worms and health span in monkeys.
- A 2025 Aging Cell study in 137 men aged 20–93 found no association between circulating taurine and age or physical performance — and was published under the title “experimental evidence against” the original hypothesis.
- No adequately powered randomised trial has tested whether taurine supplementation improves health span in humans. The authors of the original paper said as much in their own conclusion.
Short answer: taurine has one of the most striking animal datasets in modern ageing research and one of the least settled human pictures. The 2023 paper was strong work and did not overclaim. The 2025 human analysis pushed back hard on the central premise. Anyone selling you certainty in either direction is ahead of the evidence, and the honest position is that this is an open question with a genuinely interesting mechanism attached.
What did the 2023 study actually find?
It found that circulating taurine concentrations decline with age in mice, monkeys and humans, and that reversing that decline through supplementation increased health span in mice and monkeys and lifespan in mice and worms. Yeast showed no lifespan benefit — a detail worth keeping, because it shows the effect is not universal across all organisms tested.
The mechanistic work was the impressive part. Taurine supplementation reduced cellular senescence, protected against telomerase deficiency, suppressed mitochondrial dysfunction, decreased DNA damage and attenuated inflammaging — several distinct hallmarks of ageing moving together. In humans, lower taurine concentrations correlated with multiple age-related diseases, and taurine and its metabolites rose after acute endurance exercise.
Those individual hallmarks each have their own literature. We cover the senescence side in zombie cells and cellular senescence and the inflammatory side in inflammaging.
What did the 2025 rebuttal find?
A team assessed whether circulating taurine was associated with ageing and physical performance in 137 physically inactive and physically active men aged 20 to 93. The paper was published in Aging Cell under a title that leaves little room for interpretation: experimental evidence against taurine deficiency as a driver of ageing in humans.
The authors also raised a pointed methodological criticism of the original human data: the reported correlation between taurine and age appeared to be driven substantially by individuals aged 20 and under, and participants over 65 were underrepresented. If the human decline curve is largely a childhood-to-adulthood transition rather than a decline across adult life, the implication for supplementing a 55-year-old changes considerably.
Study snapshot
| Design | Cross-sectional analysis of circulating taurine, age and physical performance |
| n / population | 137 men, aged 20–93, both physically inactive and active |
| Journal | Aging Cell 2025;24(10):e70191 |
| Finding | No association supporting taurine deficiency as an ageing driver in humans |
| Limitation | Men only; cross-sectional; a single cohort cannot settle the question either |
What human intervention evidence exists?
Very little, and it is small. A controlled clinical trial examined taurine’s antioxidant activity in women aged 55 to 70, published in Nutrition in 2022. It is one modest study on a biomarker outcome, not a health span trial.
The original authors explicitly called for the trial that has not happened. Their published conclusion stated that clinical trials in humans seem warranted to test whether taurine deficiency might drive ageing in humans. That is a research group being appropriately careful about the boundary of their own findings, and it is the sentence most often left out of supplement marketing built on the paper.
The honest counterweight: cross-species extrapolation has a poor track record in ageing research. Compounds that extend lifespan in worms and mice have repeatedly failed to translate. The gap between a health span effect in monkeys and a meaningful outcome in humans is the hardest part of this entire field, and taurine has not crossed it.
Is there a plausible energy angle?
Taurine is one of the most abundant free amino acids in human tissue, concentrated in heart, muscle and retina. It has documented roles in bile salt conjugation, osmoregulation, calcium handling and mitochondrial protein synthesis. Muscle taurine content is genuinely high and it does rise acutely with endurance exercise.
But abundance is not the same as being rate-limiting. Something can be present in large quantities precisely because the body maintains it well, in which case adding more changes little. No human trial has shown taurine supplementation improving subjective energy or fatigue.
What taurine won’t do
It will not do in you what it did in mice. Mouse lifespan studies use lifelong or near-lifelong supplementation at doses that do not scale straightforwardly to human physiology, in animals with far faster metabolic clocks.
It also should not be inferred from energy drinks. The taurine content of those products sits alongside large amounts of caffeine and sugar, and whatever people attribute to taurine in that context is almost certainly caffeine.
If you want to try it anyway
Human studies have typically used doses in the range of one to a few grams per day, which is achievable and generally well tolerated. Dietary taurine comes largely from meat, fish and shellfish; strict plant-based diets provide almost none, which is one genuinely defensible reason a person might consider supplementing.
Set your expectations against the evidence: this is a bet on a mechanism, not a purchase of a demonstrated outcome. If you approach other amino-acid-based interventions the same way — see our assessment of GlyNAC — you will be calibrated about right. The same discipline applies to any longevity compound whose mechanism has outrun its human trials, which is exactly the situation we describe in what a 12-month spermidine trial actually showed.
Frequently asked questions
Does taurine definitely decline with age in humans?
This is exactly what is disputed. The 2023 paper reported a decline; the 2025 analysis argued the human correlation was driven largely by participants aged 20 and under, with few over 65. Both datasets exist and they disagree.
Is taurine in energy drinks doing anything?
Almost certainly not much that you would notice. The alerting effect of those products is overwhelmingly attributable to caffeine, and no trial has isolated a perceptible taurine contribution in that setting.
Should vegetarians and vegans supplement taurine?
It is the most defensible case, since dietary taurine comes mainly from animal foods. That said, humans synthesise taurine endogenously from cysteine, and clinical deficiency in healthy adults on plant-based diets is not a well-established phenomenon.
Does taurine interact with NAD+ pathways?
Not directly. The 2023 study reported taurine affecting mitochondrial function and senescence, which overlaps conceptually with NAD+ biology, but the mechanisms are distinct and no trial has tested them together.
Why has nobody run the human trial yet?
Health span trials are expensive, long, and hard to design endpoints for. Taurine is also unpatentable, which removes the commercial incentive that funds most large trials. That is a structural problem across the whole nutrition field, not a knock on taurine.
From Nuvirox
Why we formulated NAD+ Restore.
We are not going to tell you taurine does nothing. We will say that NAD+ precursors have completed the human intervention trials that taurine has not, which is why NAD+ Restore is built the way it is.
- 500 mg Nicotinamide Riboside Chloride (NR) — one of the two most-researched NAD+ precursors, within the dose range used in published human trials.
- 150 mg trans-resveratrol (Japanese Knotweed) + 50 mg quercetin (Sophora japonica) — polyphenols studied alongside NAD+ pathways for cellular health support.
- 10 mg galactomannans from fenugreek — to support absorption.
- 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
The bottom line
Taurine is a genuinely interesting molecule with a genuinely unresolved human story. The 2023 Science paper was careful work that explicitly called for human trials rather than declaring victory; the 2025 Aging Cell analysis pushed back on the central human premise and did so in a peer-reviewed venue. Neither is the last word. What we can say is that no adequately powered randomised trial has tested taurine for health span or fatigue in people, that the strongest evidence sits in worms and mice, and that the one clear practical case is dietary — people eating no animal foods get almost none. That is a reasonable basis for a modest personal experiment and a poor basis for confident claims.
References
- Singh P, Gollapalli K, Mangiola S, et al. Taurine deficiency as a driver of aging. Science. 2023;380(6649):eabn9257. PMID: 37289866. DOI: 10.1126/science.abn9257.
- Marcangeli V, Cefis M, Hammad R, et al. Experimental evidence against taurine deficiency as a driver of aging in humans. Aging Cell. 2025;24(10):e70191. PMID: 41061678. PMCID: PMC12507425.
- Abud GF, De Carvalho FG, Batitucci G, et al. Taurine as a possible antiaging therapy: a controlled clinical trial on taurine antioxidant activity in women ages 55 to 70. Nutrition. 2022;101:111706.
- Kumar P, Liu C, Suliburk J, et al. Supplementing glycine and N-acetylcysteine (GlyNAC) in older adults improves glutathione deficiency, oxidative stress, mitochondrial dysfunction, inflammation, physical function, and aging hallmarks: a randomized clinical trial. The Journals of Gerontology: Series A. 2023;78(1):75-89. PMID: 35975308. DOI: 10.1093/gerona/glac135.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.